[The possibilities of element status evaluation in determination of antiviral therapy resistance in patients with chronic hepatitis C].
Bakulin
I G
IG
Novozhenov
V G
VG
Ivanova
M A
MA
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use; D001151:Arsenic / Q000097:blood*; D016022:Case-Control Studies; D024882:Drug Resistance, Viral; D004359:Drug Therapy, Combination; D004602:Elements; D005260:Female; D016174:Hepacivirus / Q000302:isolation & purification; D019698:Hepatitis C, Chronic / Q000175:diagnosis* / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D008297:Male; D008670:Metals / Q000097:blood*; D008875:Middle Aged; D010758:Phosphorus / Q000097:blood*; D011994:Recombinant Proteins; D016896:Treatment Outcome
D000998:Antiviral Agents; D004602:Elements; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D008670:Metals; D011994:Recombinant Proteins; D010758:Phosphorus; D001151:Arsenic